Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0145 USD | 0.00% | +12.40% | -77.34% |
May. 16 | Transcript : Evofem Biosciences, Inc. - Special Call | |
May. 15 | Evofem Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-77.34% | 1.06M | |
+39.24% | 727B | |
+30.57% | 592B | |
-7.92% | 347B | |
+15.44% | 319B | |
-0.63% | 274B | |
+12.55% | 238B | |
+6.65% | 204B | |
-6.09% | 203B | |
-3.16% | 160B |
- Stock Market
- Equities
- EVFM Stock
- News Evofem Biosciences, Inc.
- Evofem Biosciences : Morgan Stanley Downgrades Evofem Biosciences to Underweight Rating From Equal-Weight, Lowers PT to $0.80 From $1